Patient Care

Complex Genomic Features Underlying CAR T-Cell Failures in Lymphoma

06.21.22

Complex Genomic Features Underlying CAR T-Cell Failures in Lymphoma

by ASTCT Science Highlights

CART-ddBCMA for Treatment of Multiple Myeloma

06.16.22

CART-ddBCMA for Treatment of Multiple Myeloma

by ASTCT Science Highlights

CAR T-Cell Product Type and Outcomes in B-NHL

06.14.22

CAR T-Cell Product Type and Outcomes in B-NHL

by ASTCT Science Highlights

ZUMA-12: Axi-cel “Highly Effective” as First-Line Therapy in High-Risk LBCL

05.23.22

ZUMA-12: Axi-cel “Highly Effective” as First-Line Therapy in High-Risk LBCL

by ASTCT

CAR T Therapy “May Be an Option” for CNS Leukemia

05.18.22

CAR T Therapy “May Be an Option” for CNS Leukemia

by ASTCT

TCR-Independent Activation with Src- Kinase Inhibitor Improves CAR T Cell Attributes

05.05.22

TCR-Independent Activation with Src- Kinase Inhibitor Improves CAR T Cell Attributes

by ASTCT Science Highlights

Lenalidomide plus CD23.CAR T Cell Therapy in CLL

05.03.22

Lenalidomide plus CD23.CAR T Cell Therapy in CLL

by ASTCT Science Highlights

In Vivo Imaging of Nanoparticle-Labeled CAR T Cells

04.07.22

In Vivo Imaging of Nanoparticle-Labeled CAR T Cells

by ASTCT Science Highlights

Fludarabine Exposure CD19 CAR T-Cell Therapy

04.05.22

Fludarabine Exposure CD19 CAR T-Cell Therapy

by ASTCT Science Highlights

THANK YOU TO OUR SPONSORS